Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function.

Autor: Yin, Wei1 wei.yin@takeda.com, Mitra, Pranab1, Copalu, Veronique1, Marbury, Thomas C.2, Rondon, Juan Carlos3, Lawitz, Eric J.4, Lloyd, Valerie1, Baratta, Mike1, Asgharnejad, Mahnaz1, Hui, Tom1, Khan, Yasir1
Zdroj: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-12. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje